NO323623B1 - Isolert og renset TNF-<alfa>-omdannende enzym (TACE)-polypeptid med evnen til a omdanne TNF-<alfa> fra formen pa 26 kD til formen pa 17 kD, isolerte og rensede antistoffer, fremgangsmate for pavisning av den TACE-inhiberende aktivitet til et molekyl, isolert nukleinsyre, ekspresjonsvektor, vertcelle, fremgangsmate for fremstilling av et TNF-<alfa>-omdannende enzym (TACE)- polypeptid, anvendelse av TNF-<alfa>-omdannende enzym (TACE)- polypeptid for fremstilling av et medikament for behandling av tumorer, inflammasjon eller fertilitetsforstyrrelser. - Google Patents

Isolert og renset TNF-<alfa>-omdannende enzym (TACE)-polypeptid med evnen til a omdanne TNF-<alfa> fra formen pa 26 kD til formen pa 17 kD, isolerte og rensede antistoffer, fremgangsmate for pavisning av den TACE-inhiberende aktivitet til et molekyl, isolert nukleinsyre, ekspresjonsvektor, vertcelle, fremgangsmate for fremstilling av et TNF-<alfa>-omdannende enzym (TACE)- polypeptid, anvendelse av TNF-<alfa>-omdannende enzym (TACE)- polypeptid for fremstilling av et medikament for behandling av tumorer, inflammasjon eller fertilitetsforstyrrelser. Download PDF

Info

Publication number
NO323623B1
NO323623B1 NO19975438A NO975438A NO323623B1 NO 323623 B1 NO323623 B1 NO 323623B1 NO 19975438 A NO19975438 A NO 19975438A NO 975438 A NO975438 A NO 975438A NO 323623 B1 NO323623 B1 NO 323623B1
Authority
NO
Norway
Prior art keywords
tace
tnf
polypeptide
isolated
converting enzyme
Prior art date
Application number
NO19975438A
Other languages
English (en)
Norwegian (no)
Other versions
NO975438L (no
NO975438D0 (no
Inventor
Roy A Black
Douglas Pat Cerretti
Charles Rauch
Carl J March
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/655,345 external-priority patent/US5830742A/en
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of NO975438D0 publication Critical patent/NO975438D0/no
Publication of NO975438L publication Critical patent/NO975438L/no
Publication of NO323623B1 publication Critical patent/NO323623B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Heart & Thoracic Surgery (AREA)
NO19975438A 1995-06-08 1997-11-26 Isolert og renset TNF-<alfa>-omdannende enzym (TACE)-polypeptid med evnen til a omdanne TNF-<alfa> fra formen pa 26 kD til formen pa 17 kD, isolerte og rensede antistoffer, fremgangsmate for pavisning av den TACE-inhiberende aktivitet til et molekyl, isolert nukleinsyre, ekspresjonsvektor, vertcelle, fremgangsmate for fremstilling av et TNF-<alfa>-omdannende enzym (TACE)- polypeptid, anvendelse av TNF-<alfa>-omdannende enzym (TACE)- polypeptid for fremstilling av et medikament for behandling av tumorer, inflammasjon eller fertilitetsforstyrrelser. NO323623B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US48245895A 1995-06-08 1995-06-08
US50461495A 1995-07-20 1995-07-20
US08/655,345 US5830742A (en) 1995-06-08 1996-05-23 TNF-α converting enzyme
PCT/US1996/008407 WO1996041624A1 (fr) 1995-06-08 1996-06-03 Enzyme de conversion du facteur de necrose tumorale alpha

Publications (3)

Publication Number Publication Date
NO975438D0 NO975438D0 (no) 1997-11-26
NO975438L NO975438L (no) 1998-02-06
NO323623B1 true NO323623B1 (no) 2007-06-18

Family

ID=27413615

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975438A NO323623B1 (no) 1995-06-08 1997-11-26 Isolert og renset TNF-<alfa>-omdannende enzym (TACE)-polypeptid med evnen til a omdanne TNF-<alfa> fra formen pa 26 kD til formen pa 17 kD, isolerte og rensede antistoffer, fremgangsmate for pavisning av den TACE-inhiberende aktivitet til et molekyl, isolert nukleinsyre, ekspresjonsvektor, vertcelle, fremgangsmate for fremstilling av et TNF-<alfa>-omdannende enzym (TACE)- polypeptid, anvendelse av TNF-<alfa>-omdannende enzym (TACE)- polypeptid for fremstilling av et medikament for behandling av tumorer, inflammasjon eller fertilitetsforstyrrelser.

Country Status (13)

Country Link
EP (1) EP0830130B9 (fr)
JP (1) JP4326022B2 (fr)
AT (1) ATE274346T1 (fr)
AU (1) AU712759C (fr)
CA (1) CA2222650C (fr)
DE (1) DE69633231T2 (fr)
DK (1) DK0830130T3 (fr)
ES (1) ES2227598T3 (fr)
IL (1) IL122305A0 (fr)
NO (1) NO323623B1 (fr)
NZ (2) NZ510390A (fr)
PT (1) PT830130E (fr)
WO (1) WO1996041624A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180403B1 (en) 1999-10-28 2001-01-30 Isis Pharmaceuticals Inc. Antisense inhibition of tumor necrosis factor alpha converting enzyme (TACE) expression
US6255064B1 (en) 1996-03-01 2001-07-03 The Procter & Gamble Company Disintegrin metalloprotease and its use
WO1997035538A2 (fr) * 1996-03-26 1997-10-02 Glaxo Group Limited Convertase du facteur alpha de necrose tumorale
AU3514997A (en) * 1996-07-12 1998-02-09 Schering Corporation Mammalian tnf-alpha convertases
US5853977A (en) 1996-07-12 1998-12-29 Schering Corporation Mammalian TNF-α convertases
US6046031A (en) * 1997-01-21 2000-04-04 Human Genome Sciences, Inc. Metalloproteinases
EP0977775A2 (fr) * 1997-02-25 2000-02-09 The Procter & Gamble Company Utilisation d'une nouvelle proteine metalloprotease disintegrine, mutants, fragments et analogues de ladite proteine
US6551857B2 (en) 1997-04-04 2003-04-22 Elm Technology Corporation Three dimensional structure integrated circuits
US6548633B1 (en) 1998-12-22 2003-04-15 Genset, S.A. Complementary DNA's encoding proteins with signal peptides
DE69936445T2 (de) * 1998-02-04 2008-04-10 Immunex Corp., Seattle Kristallines tnf-alpha-konvertierendes enzym und verwendung davon
US6842704B2 (en) 1998-02-04 2005-01-11 Immunex Corporation Crystalline TNF-α-converting enzyme and uses thereof
US6632667B1 (en) 1999-10-28 2003-10-14 Isis Pharmaceuticals, Inc. Modulation of L-selectin shedding via inhibition of tumor necrosis factor-α converting enzyme (TACE)
EP1449538A1 (fr) * 2003-02-21 2004-08-25 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Inhibition de TACE ou amphirégulin pour moduler la transactivation de signaux récepteur EGF
WO2005030798A2 (fr) 2003-09-24 2005-04-07 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Agents inhibiteurs et agents stimulateurs de l'enzyme de conversion du tnf-$g(a)
KR101770312B1 (ko) 2006-08-28 2017-08-22 아레스 트레이딩 에스.에이. Ｆｃ­함유 단백질을 정제하는 방법
US20100267932A1 (en) * 2006-08-28 2010-10-21 Alex Eon-Duval Process for the purification of fc-fusion proteins
AU2012213240A1 (en) 2011-02-01 2013-08-15 Cancer Research Technology Limited Anti-TACE antibody molecules and their uses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE148992T1 (de) * 1989-08-16 1997-03-15 Chiron Corp Zusammensetzungen zur hemmung der bildung von proteinhormon und deren verwendungen
EP0487610B1 (fr) * 1989-08-16 2000-02-09 Chiron Corporation Anticorps prohormone pour blocage du site de clivage
WO1992000378A1 (fr) * 1990-06-22 1992-01-09 GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) Sequence d'adn pour une protease de serine et objets s'y rapportant
DE69132470D1 (de) * 1990-08-06 2000-12-21 Chiron Corp Verfahren zum nachweis von cytokinkonvertasehemmern
CA2139127A1 (fr) * 1992-06-25 1994-01-06 Chiron Corporation Compositions permettant d'inhiber la formation d'hormones proteiques et leur utilisation
EP0749494A1 (fr) * 1994-03-07 1996-12-27 Chiron Corporation Compositions pour l'inhibition de la formation des facteurs de necrose tumorale (tnf) et leur utilisation
WO1997035538A2 (fr) * 1996-03-26 1997-10-02 Glaxo Group Limited Convertase du facteur alpha de necrose tumorale

Also Published As

Publication number Publication date
AU6378196A (en) 1997-01-09
PT830130E (pt) 2004-11-30
DE69633231D1 (de) 2004-09-30
WO1996041624A1 (fr) 1996-12-27
MX9709744A (es) 1998-07-31
AU712759B2 (en) 1999-11-18
CA2222650C (fr) 2009-10-13
ES2227598T3 (es) 2005-04-01
NZ510390A (en) 2002-11-26
NZ312285A (en) 2001-04-27
NO975438L (no) 1998-02-06
EP0830130B1 (fr) 2004-08-25
EP0830130B9 (fr) 2004-12-29
EP0830130A1 (fr) 1998-03-25
IL122305A0 (en) 1998-04-05
JP2002515020A (ja) 2002-05-21
EP0830130A4 (fr) 2000-03-29
JP4326022B2 (ja) 2009-09-02
ATE274346T1 (de) 2004-09-15
DE69633231T2 (de) 2005-08-04
DK0830130T3 (da) 2004-12-20
CA2222650A1 (fr) 1996-12-27
NO975438D0 (no) 1997-11-26
AU712759C (en) 2001-08-09

Similar Documents

Publication Publication Date Title
US7695948B2 (en) Antibodies that bind TNF-α converting enzyme
US5830742A (en) TNF-α converting enzyme
NO323623B1 (no) Isolert og renset TNF-&lt;alfa&gt;-omdannende enzym (TACE)-polypeptid med evnen til a omdanne TNF-&lt;alfa&gt; fra formen pa 26 kD til formen pa 17 kD, isolerte og rensede antistoffer, fremgangsmate for pavisning av den TACE-inhiberende aktivitet til et molekyl, isolert nukleinsyre, ekspresjonsvektor, vertcelle, fremgangsmate for fremstilling av et TNF-&lt;alfa&gt;-omdannende enzym (TACE)- polypeptid, anvendelse av TNF-&lt;alfa&gt;-omdannende enzym (TACE)- polypeptid for fremstilling av et medikament for behandling av tumorer, inflammasjon eller fertilitetsforstyrrelser.
CA2296766C (fr) Metalloproteases decomposant l&#39;aggrecan
JP2000506005A (ja) ２ｆ１と呼ばれる受容体タンパク質
EP1045905A2 (fr) Adn codant il-17rh et polypeptides il-17rh
JP2002500011A (ja) Ｖ２０１ｄｎａ及びポリペプチド
US20090017492A1 (en) SVPH1-26 DNA and polypeptides
AU752369B2 (en) TNF-alpha converting enzyme
JP2002508969A (ja) 精巣特異的ヒトｓｖｐｈ１−８プロテイナーゼ
AU745623B2 (en) V196 DNA and polypeptides
MXPA97009744A (en) Enzima convertidora tnf-a
WO1999033984A1 (fr) Adn et polypeptides v197

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees